The medicinal chemistry of multidrug resistance (MDR) reversing drugs
- 23 April 2002
- journal article
- review article
- Published by Elsevier in Il Farmaco
- Vol. 57 (5), 385-415
- https://doi.org/10.1016/s0014-827x(02)01229-6
Abstract
No abstract availableKeywords
This publication has 254 references indexed in Scilit:
- Inhibition of P-Glycoprotein Activity and Chemosensitization of Multidrug-Resistant Ovarian Carcinoma 2780AD Cells by HexanoylglucosylceramideBiochemical and Biophysical Research Communications, 1999
- Reversal of MRP-Mediated Multidrug Resistance in Human Lung Cancer Cells by the Antiprogestatin Drug RU486Biochemical and Biophysical Research Communications, 1999
- Direct Interaction between a Quinoline Derivative, MS-209, and Multidrug Resistance Protein (MRP) in Human Gastric Cancer CellsBiochemical and Biophysical Research Communications, 1999
- Experimental reversal of P-glycoprotein-mediated multidrug resistance by pharmacological chemosensitisersEuropean Journal Of Cancer, 1996
- Pharmacological considerations in the modulation of multidrug resistanceEuropean Journal Of Cancer, 1996
- P-glycoprotein—A mediator of multidrug resistance in tumour cellsEuropean Journal Of Cancer, 1996
- Reversal of Multidrug Resistance by Valinomycin is Overcome by CCCPBiochemical and Biophysical Research Communications, 1996
- Membrane interactions of some catamphiphilic drugs and relation to their multidrug-resistance-reversing abilityZeitschrift für Krebsforschung und Klinische Onkologie, 1996
- The dithiane Ro 44-5912 enhances vinblastine sensitivity of drug resistant and parental KB lines in vivoEuropean Journal Of Cancer, 1995
- Tamoxifen Aziridine, a Novel Affinity Probe for P-Glycoprotein in Multidrug-Resistant CellsBiochemical and Biophysical Research Communications, 1994